BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22198047)

  • 1. Effect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats.
    Davidson EP; Coppey LJ; Holmes A; Yorek MA
    Eur J Pharmacol; 2012 Feb; 677(1-3):180-7. PubMed ID: 22198047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats.
    Oltman CL; Davidson EP; Coppey LJ; Kleinschmidt TL; Dake B; Yorek MA
    Eur J Pharmacol; 2011 Jan; 650(2-3):556-62. PubMed ID: 21040718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications.
    Davidson EP; Coppey LJ; Holmes A; Dake B; Yorek MA
    Eur J Pharmacol; 2011 Oct; 668(3):497-506. PubMed ID: 21816138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat.
    Davidson EP; Holmes A; Coppey LJ; Yorek MA
    Eur J Pharmacol; 2015 Oct; 765():258-67. PubMed ID: 26291662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor: effect on vascular and neural disease.
    Davidson EP; Kleinschmidt TL; Oltman CL; Lund DD; Yorek MA
    Diabetes; 2007 Feb; 56(2):355-62. PubMed ID: 17259379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J mice.
    Coppey L; Davidson E; Lu B; Gerard C; Yorek M
    Neuropharmacology; 2011; 60(2-3):259-66. PubMed ID: 20849865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction.
    Oltman CL; Davidson EP; Coppey LJ; Kleinschmidt TL; Yorek MA
    Diabetes Obes Metab; 2009 Mar; 11(3):223-33. PubMed ID: 18564175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of streptozotocin-induced diabetic rats with alogliptin: effect on vascular and neural complications.
    Davidson EP; Coppey LJ; Dake B; Yorek MA
    Exp Diabetes Res; 2011; 2011():810469. PubMed ID: 21822422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired Corneal Sensation and Nerve Loss in a Type 2 Rat Model of Chronic Diabetes Is Reversible With Combination Therapy of Menhaden Oil, α-Lipoic Acid, and Enalapril.
    Davidson EP; Coppey LJ; Shevalye H; Obrosov A; Kardon RH; Yorek MA
    Cornea; 2017 Jun; 36(6):725-731. PubMed ID: 28476051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats.
    Coppey LJ; Davidson EP; Rinehart TW; Gellett JS; Oltman CL; Lund DD; Yorek MA
    Diabetes; 2006 Feb; 55(2):341-8. PubMed ID: 16443766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice.
    Coppey L; Lu B; Gerard C; Yorek MA
    J Obes; 2012; 2012():326806. PubMed ID: 23056927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early loss of innervation of cornea epithelium in streptozotocin-induced type 1 diabetic rats: improvement with ilepatril treatment.
    Davidson EP; Coppey LJ; Yorek MA
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8067-74. PubMed ID: 23169880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.
    Tikkanen T; Tikkanen I; Rockell MD; Allen TJ; Johnston CI; Cooper ME; Burrell LM
    Hypertension; 1998 Oct; 32(4):778-85. PubMed ID: 9774379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Salvemini D; Yorek MA
    Br J Pharmacol; 2001 Sep; 134(1):21-9. PubMed ID: 11522593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Yorek MA
    Diabetes; 2001 Aug; 50(8):1927-37. PubMed ID: 11473057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes.
    Tikkanen I; Tikkanen T; Cao Z; Allen TJ; Davis BJ; Lassila M; Casley D; Johnston CI; Burrell LM; Cooper ME
    J Hypertens; 2002 Apr; 20(4):707-14. PubMed ID: 11910307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Kuro T; Okahara A; Nose M; Ikuse T; Matsumura Y
    Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-atherosclerotic and renoprotective effects of combined angiotensin-converting enzyme and neutral endopeptidase inhibition in diabetic apolipoprotein E-knockout mice.
    Jandeleit-Dahm K; Lassila M; Davis BJ; Candido R; Johnston CI; Allen TJ; Burrell LM; Cooper ME
    J Hypertens; 2005 Nov; 23(11):2071-82. PubMed ID: 16208151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction.
    Davidson EP; Coppey LJ; Calcutt NA; Oltman CL; Yorek MA
    Diabetes Metab Res Rev; 2010 May; 26(4):306-18. PubMed ID: 20503263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin I-converting enzyme-dependent and neutral endopeptidase-dependent generation and degradation of angiotensin II contrarily modulate noradrenaline release: implications for vasopeptidase-inhibitor therapy?
    Raasch W; Dominiak P; Dendorfer A
    J Hypertens; 2005 Aug; 23(8):1597-604. PubMed ID: 16003188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.